Globus Medical (GMED) Capital Expenditures Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Globus Medical | 10.79 Bn | 10.16 Bn | 525.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.71% |
| Dec 31, 2025 | 20.42% |
| Sep 30, 2025 | -98.89% |
| Jun 30, 2025 | 121.77% |
| Mar 31, 2025 | 46.85% |
| Dec 31, 2024 | 64.03% |
| Sep 30, 2024 | 25.68% |
| Jun 30, 2024 | 28.15% |
| Mar 31, 2024 | -28.06% |
| Sep 30, 2023 | 8.99% |
| Jun 30, 2023 | -22.14% |
| Mar 31, 2023 | 5.26% |
| Dec 31, 2022 | -41.12% |
| Sep 30, 2022 | 31.65% |
| Jun 30, 2022 | -41.66% |
| Mar 31, 2022 | -18.67% |
| Dec 31, 2021 | -40.49% |
| Sep 30, 2021 | -14.95% |
| Jun 30, 2021 | -24.08% |
| Mar 31, 2021 | 7.86% |
| Dec 31, 2020 | 33.37% |
| Sep 30, 2020 | -17.01% |
| Jun 30, 2020 | -45.41% |
| Mar 31, 2020 | -6.06% |
| Dec 31, 2019 | -16.98% |
| Sep 30, 2019 | -66.45% |
| Jun 30, 2019 | 19.43% |
| Mar 31, 2019 | 35.50% |
| Sep 30, 2018 | 42.59% |
| Jun 30, 2018 | 19.06% |
| Mar 31, 2018 | 12.81% |
| Dec 31, 2017 | 11.90% |
| Sep 30, 2017 | 19.85% |
| Jun 30, 2017 | 19.57% |
| Mar 31, 2017 | 12.81% |
| Dec 31, 2016 | 15.90% |
| Sep 30, 2016 | 12.47% |